FUZE: INTRAMEDULLARY INTERNAL FIXATION NAIL
K102413 · Vilex, Inc. · HSB · Nov 14, 2011 · Orthopedic
Device Facts
| Record ID | K102413 |
| Device Name | FUZE: INTRAMEDULLARY INTERNAL FIXATION NAIL |
| Applicant | Vilex, Inc. |
| Product Code | HSB · Orthopedic |
| Decision Date | Nov 14, 2011 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 888.3020 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
Ankle Arthrodesis, Tibio-talo-calcaneal Arthrodesis
Device Story
FUZE Intramedullary Internal Fixation Nail is a single-piece, cannulated metallic implant designed for ankle and tibio-talo-calcaneal arthrodesis; used to fuse ankle joints. System includes implant, locking cross-screws, and instrumentation (drills, reamers, screwdrivers, guide wires, Steinman pins). Targeting device is radiolucent to assist screw insertion. Implant is inserted into tibia and foot; secured with locking screws to provide mechanical fixation and compression of joints. Used in clinical/surgical settings by orthopedic surgeons. Benefits include stabilization and fusion of ankle/hindfoot joints.
Clinical Evidence
No clinical data. Substantial equivalence supported by engineering analysis, cadaver testing, sawbones testing, and component mechanical testing.
Technological Characteristics
Materials: 316L VM stainless steel (ASTM 138) or Ti6Al4V titanium alloy (ASTM 136). Design: Cannulated, single-piece intramedullary nail with locking cross-screws. Modular system includes radiolucent targeting device and surgical instrumentation. Mechanical fixation via intramedullary placement.
Indications for Use
Indicated for patients requiring ankle arthrodesis or tibio-talo-calcaneal arthrodesis.
Regulatory Classification
Identification
An intramedullary fixation rod is a device intended to be implanted that consists of a rod made of alloys such as cobalt-chromium-molybdenum and stainless steel. It is inserted into the medullary (bone marrow) canal of long bones for the fixation of fractures.
Predicate Devices
- Ankle Fusion Nail (VALORTM) (K090857)
- Titanium Ankle Arthrodesis Nail (Phoenix) (K021786)
- TriGen Hindfoot Fusion Nail (K043052)
- T2 Ankle Arthrodesis Nail (K051590)
- Panta Arthrodesis Nail (K091788)
Related Devices
- K091976 — BIOMET PHOENIX ANKLE NAIL AND ANKLE ARTHRODESIS NAIL · Biomet Trauma · Aug 17, 2009
- K112982 — ANATOMIC ANKLE ARTHRODESIS INTERLOCKING NAIL(A3 INTERLOCKING NAIL ) · Small Bone Innovations, Inc. · Apr 2, 2012
- K221031 — Arthrex DualCompression Hindfoot Fusion Nail Implant System · Arthrex, Inc. · Dec 20, 2022
- K163627 — Shotel Ankle Arthrodesis Nail System · Biopro, Inc. · Sep 14, 2017
- K192163 — TTC Phantom® Intramedullary Nail System · Paragon 28, Inc. · Jan 31, 2020
Submission Summary (Full Text)
{0}------------------------------------------------
## 510(k) K102413: Summary
In accordance with the Food and Drug Administration Rule to implement provisions of the Safe Medical Devices Act of 1990 and in conformance with 21 CRF 807, this information serves as a Summary of Safety and Effectiveness for the use of the FUZE®: Intramedullary Arthrodesis Nail System.
| Sponsor: | Vilex in Tennessee, Inc., 111 Moffitt St., McMinnville, TN 37110,<br>931-474-7550 |
|----------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact: | Sylvia Southard Date: Nov 8, 2011 |
| Device Name: | FUZE®: Intramedullary Internal Fixation Nail |
| Classification: | 21 CFR 888.3020 – “Intramedullary Nail”<br>21 CFR 888.3030 Single/Multiple component metallic bone fixation appliances and accessories<br>Product Code HSB, Class II |
| Predicate Devices: | K090857 Ankle Fusion Nail (VALORTM) |
| | K021786 Titanium Ankle Arthrodesis Nail (Phoenix) |
| | K043052 TriGen Hindfoot Fusion Nail |
| | K051590 T2 Ankle Arthrodesis Nail |
| | K091788 Panta Arthrodesis Nail |
| Description of<br>Device: | The Vilex FUZETM is a single-piece intramedullary nail fixed to the tibia and foot with locking cross<br>screws for fusing the ankle joint(s). The FUZETM is a straight cannulated metallic implant offered in five<br>diameters and various lengths in either 316L VM (ASTM 138) stainless steel or Ti6Al4V titanium alloy<br>(ASTM 136). The FUZETM System is a modular system consisting of the implant, locking screws, and<br>instrumentation for fixation. The screws, (offered in one diameter and various lengths), are manufactured<br>from identical materials (either stainless steel or titanium alloy, matching the implant). The targeting<br>device is radio translucent, designed to lock into the FUZETM for the correct insertion of the locking<br>screws. The system also includes drills, reamers, screwdrivers, guide wires and Steinman pins. |
| Substantial<br>Equivalence | Engineering analysis, cadaver, sawbones, and components tests confirm that the design possesses the<br>mechanical integrity necessary for this application and implant can compress the tibi-talo-calcaneal<br>joints. The design features of the FUZETM Intramedullary Arthrodesis Nail System are substantially<br>equivalent to the design features of other predicate devices previously cleared for market. The methods<br>used to establish equivalence are indications for use, material of construction, sizes, hole locations, and<br>shape. The safety and effectiveness of the FUZETM is adequately supported by the substantial<br>equivalence information, material information and analysis data provided within this Premarket<br>Notification. |
| Material: | Titanium Ti6Al4V, ASTM 136 or stainless steel alloy 316L ASTM 138, suitable for human implanting |
| Indications for Use: | Ankle Arthrodesis, Tibio-talo-calcaneal Arthrodesis |
| Establishment Reg.<br>No.: | 1051526 |
{1}------------------------------------------------
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of an eagle or bird in flight, composed of three curved lines. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular fashion around the bird symbol.
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002
NOV 1 4 2011
Vilex, Inc. % Ms. Sylvia Southard 111 Moffitt Street McMinnville, Tennessee 37110
Re: K102413
Trade/Device Name: FUZE Intramedullary Internal Fixation Nail Regulation Number: 21 CFR 888.3020 Regulation Name: Intramedullary fixation rod Regulatory Class: II Product Code: HSB Dated: November 8, 2011 Received: November 9, 2011
Dear Ms. Southard:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
{2}------------------------------------------------
## Page 2 – Ms. Sylvia Southard
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
Erin S. Keith
Mark N. Melkerson · Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
## Indications for Use
510(k) Number (if known): K102413
Device Name: FUZE: INTRAMEDULLARY INTERNAL FIXATION NAIL
Indications For Use:
The Vilex FUZE has the following Indications for Use
## Ankle Arthordesis, Tibio-talo-calacaneal Arthrodesis
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR Over-The-Counter Use __________________________________________________________________________________________________________________________________________________ (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
ivision Sign-Oft) ivision of Surgical, Orthopedic, and Restorative Devices
510(k) Number K102413
Page 1 of 1